France: Domitille de Vienne joins Andera Partners
Domitille de Vienne has joined France-based Andera Partners as a director within its MidCap team, focusing on private equity investments in France.
She joins from...
UK: Toscafund makes £1bn bid for Spire Healthcare
Spire Healthcare has received a non-binding proposal from Toscafund Asset Management, the UK hospital group’s second largest shareholder, regarding a possible cash offer of...
France: Ajax Health invests US$60m in UroMems in support of clinical trials in US...
UroMems, a France-based global company developing implantable mechatronics technology to treat stress urinary incontinence (SUI), has raised a US$60m investment from US PE firm...
UK: CMA’s scrutiny of Welltower’s UK care home acquisitions could become defining moment for...
The UK Competition and Markets Authority’s (CMA) scrutiny of US healthcare REIT Welltower’s acquisition of more than 600 operational UK care homes could become...
UK: CVC appoints John Hourican as CFO
CVC Capital Partners has announced the appointment of John Hourican as CFO, effective 1 September, succeeding Fred Watt, who will retire from CVC after...
UK: CellCentric raises US$220m in oversubscribed Series D financing
CellCentric, a clinical-stage biotechnology company, has completed an oversubscribed US$220m Series D financing led by Venrock Healthcare Capital Partners, with participation from Fidelity Management...
UK: Amulet acquires TFP Fertility Group from Benefit Street
Amulet Capital Partners, a mid-market PE firm focused on healthcare, has acquired TFP Fertility Group, one of the leading fertility care providers in the...
Italy: Angelini Pharma enters US market and consolidates leadership in brain health with acquisition...
Angelini Pharma, the Italy-based international pharmaceutical company and part of the Angelini Industries Group, is entering the US market with the acquisition of Nasdaq-listed...
Germany: Ares invests in Linimed to support growth strategy in intensive community care and...
Linimed Gruppe, a leading provider of community‑based intensive care services in Germany, has secured capital from funds managed by Ares Management.
“Partnering with Ares marks...
Jeito Capital scales up to back Europe’s clinical-stage biopharma leaders
Jeito Capital has reached a major milestone with the final close of Jeito II at €1bn (US$1.2bn), marking the largest fundraise to date for...
Advertisement
